Analyst Consensus ?
ConsensusHold30 ratings
Bullish1136.7%
Neutral1756.7%
Bearish26.6%
Fortive Corporation · FTV · FY2025 Q4 · Calendar Q1 2026
Fortive reports strong Q4 with AI, recurring revenue and new products in focus
The current analysis supports a constructive operating thesis: Fortive paired stronger Q4 execution with raised 2026 adjusted EPS guidance, while new products, AI-enabled software and recurring revenue provide the main avenues for continued growth. The thesis is conditional on managing tariff, healthcare and industrial-demand risks.
Reported Before market openNYSETechnology
$16.94B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.90
Consensus $0.84
EPS surprise
+7.4%
Reported versus consensus
Reported revenue
$1.12B
Consensus $1.09B
Revenue surprise
+2.6%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+10.6%
Event window
SPY move
-0.5%
Same window
Abnormal move
+11.1%
Stock minus SPY
Volume
3.8×
Versus trailing sessions
Subsequent drift
-3.5%
Up to 20 sessions
FTVSPY benchmark
Ask FN2 about FTV FY2025 Q4
Transcript, numbers and history already loaded
Why did FTV rise 10.6% after beating EPS estimates in FY2025 Q4?What changed in FTV's guidance and outlook in FY2025 Q4?Give me the bull and bear case for FTV after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Fortive moved from the prior quarter's raised outlook and innovation focus to a reported Q4 with more than 3% core growth, 8% adjusted EBITDA growth, 13% adjusted EPS growth and a new 2026 adjusted EPS range of $2.90-$3.00. The company also highlighted additional product releases and continued recurring-revenue acceleration.
Guidance delta
Management raised the outlook: 2026 adjusted EPS guidance is $2.90-$3.00, following full-year 2025 adjusted EPS of $2.71.
Key takeaways
- Q4 core revenue grew more than 3%, adjusted EBITDA rose 8%, and adjusted EPS increased 13%.
- Management highlighted Fluke Certified Max and new AI-enabled ServiceChannel features as product catalysts.
- Recurring-revenue expansion and targeted investments in data centers, defense, EMEA and India remain central to the growth plan.
- Capital allocation stayed active, including $1.3 billion of share repurchases in the last two quarters.
Management priorities
- Execute the Fortive Accelerator strategy
- Launch new products and expand AI-enabled software features
- Expand recurring revenue in maintenance software and SaaS
- Pursue selective bolt-on acquisitions with strict return criteria
- Invest in sales and operating capacity in high-growth regions
Follow FTV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$55.76Current
$40Low
$71.07Average
$90High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Aug 19, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 30, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 3, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 12, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 4, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 1, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 1, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Feb 9, 2026 |
| Mizuho | Underperform | Outperform | Downgrade | Jan 5, 2026 |
| Baird | Outperform | Outperform | Maintain | Nov 4, 2025 |
| TD Cowen | Hold | Buy | Downgrade | Jul 15, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jul 1, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Sep 6, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Jan 2, 2024 |
| B of A Securities | Neutral | Buy | Downgrade | Oct 26, 2023 |
| UBS | Buy | Buy | Maintain | Oct 10, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 27, 2022 |
| Loop Capital | Buy | Buy | Maintain | Jul 19, 2022 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jun 2, 2022 |
| Rosenblatt | Neutral | Neutral | Maintain | May 4, 2021 |
| Bank of America | Buy | Buy | Maintain | Sep 5, 2019 |
| Gordon Haskett | Hold | Buy | Downgrade | Aug 5, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 26, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Oct 29, 2018 |
| Argus | Buy | Buy | Maintain | Aug 14, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Oct 27, 2017 |
| Stifel | Hold | Hold | Maintain | Oct 27, 2017 |
| Oppenheimer | Perform | Perform | Maintain | Jan 18, 2017 |
| Goldman Sachs | Neutral | Neutral | Maintain | Sep 29, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $55.76. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $67 | $61.8 | +20.2% | Jul 2, 2026 |
| Morgan Stanley | Analyst unavailable | $59 | $60.59 | +5.8% | Jun 3, 2026 |
| Argus Research | John Eade | $68 | $60.79 | +22.0% | May 11, 2026 |
| Truist Financial | Analyst unavailable | $61 | $60.73 | +9.4% | May 4, 2026 |
| Truist Financial | Analyst unavailable | $56 | $60.38 | +0.4% | Apr 20, 2026 |
| Barclays | Analyst unavailable | $63 | $60.12 | +13.0% | Feb 9, 2026 |
| Seaport Global | Analyst unavailable | $70 | $60.24 | +25.5% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $65 | $60.13 | +16.6% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $51 | $55.39 | -8.5% | Jan 5, 2026 |
| Wells Fargo | Joseph O'Dea | $59 | $54.91 | +5.8% | Dec 22, 2025 |
| Robert W. Baird | Robert Mason | $58 | $50.14 | +4.0% | Nov 4, 2025 |
| Truist Financial | Analyst unavailable | $58 | $51.38 | +4.0% | Oct 30, 2025 |
| Seaport Global | Analyst unavailable | $66 | $52.44 | +18.4% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $56 | $50.34 | +0.4% | Oct 30, 2025 |
| Mizuho Securities | Brett Linzey | $54 | $48.69 | -3.2% | Oct 17, 2025 |
| Barclays | Julian Mitchell | $54 | $48.73 | -3.2% | Aug 14, 2025 |
| Truist Financial | Jamie Cook | $55 | $49.65 | -1.4% | Jul 31, 2025 |
| Citigroup | Ronald Josey | $40 | $51.15 | -28.3% | Jul 15, 2025 |
| Barclays | Analyst unavailable | $85 | $75.93 | +52.4% | Mar 26, 2025 |
| Wells Fargo | Joseph O'Dea | $80 | $76.65 | +43.5% | Jan 7, 2025 |
| Truist Financial | Jamie Cook | $90 | $78.32 | +61.4% | Dec 19, 2024 |
| UBS | Amit Mehrotra | $84 | $68.88 | +50.6% | Nov 13, 2024 |
| Barclays | Julian Mitchell | $98 | $77.6 | +75.8% | Oct 2, 2024 |
| Morgan Stanley | Christopher Snyd | $89 | $72.8 | +59.6% | Sep 6, 2024 |
| Mizuho Securities | Brett Linzey | $90 | $72.8 | +61.4% | Sep 6, 2024 |
| Barclays | Julian Mitchell | $94 | $72.88 | +68.6% | Sep 5, 2024 |
| Raymond James | Brian Gesuale | $85 | $72.86 | +52.4% | Sep 5, 2024 |
| Robert W. Baird | Richard Eastman | $85 | $73.04 | +52.4% | Sep 5, 2024 |
| Seaport Global | Scott Graham | $88 | $70.44 | +57.8% | Jul 25, 2024 |
| RBC Capital | Deane Dray | $77 | $70.4 | +38.1% | Jul 25, 2024 |
| Barclays | Julian Mitchell | $93 | $72.64 | +66.8% | Jul 10, 2024 |
| Argus Research | John Eade | $85 | $77.06 | +52.4% | May 13, 2024 |
| Wells Fargo | Joseph O'Dea | $84 | $76.05 | +50.6% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $83 | $76.05 | +48.9% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $93 | $83.77 | +66.8% | Apr 4, 2024 |
| Truist Financial | Jamie Cook | $99 | $85.46 | +77.5% | Mar 13, 2024 |
| Citigroup | Analyst unavailable | $77 | $65.72 | +38.1% | Dec 9, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $73 | $59.95 | +30.9% | Oct 12, 2022 |
| Barclays | Julian Mitchell | $72 | $65.28 | +29.1% | Aug 4, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $64 | $63 | +14.8% | Jun 7, 2022 |
| Wells Fargo | Analyst unavailable | $65 | $58.33 | +16.6% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $65 | $58.56 | +16.6% | Apr 29, 2022 |
| Barclays | Julian Mitchell | $75 | $61.9 | +34.5% | Mar 18, 2022 |
| Robert W. Baird | Robert Mason CFA | $81 | $64.32 | +45.3% | Feb 4, 2022 |
| Mizuho Securities | Brett Linzey | $82 | $72.16 | +47.1% | Jan 19, 2022 |
| Vertical Research | Jeffrey Sprague | $82 | $73.49 | +47.1% | Jan 3, 2022 |
| Loop Capital Markets | Scott Graham | $90 | $78.5 | +61.4% | Nov 22, 2021 |
| Credit Suisse | John Walsh | $87 | $75.56 | +56.0% | Oct 29, 2021 |
| Wolfe Research | Nigel Coe | $84 | $70.24 | +50.6% | Jul 12, 2021 |
| UBS | Markus Mittermaier | $86 | $72.16 | +54.2% | May 6, 2021 |
Track every rating change on FTV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection.…
Historical context
All FTV earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the FTV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-29T01:11:00.012909+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T01:11:00.008758+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.